Current pharmacological management of gastroesophageal reflux disease.

Item

http://www.wikidata.org/entity/Q38123482

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Current pharmacological management of gastroesophageal reflux disease.

@en

type

Item

label

Current pharmacological management of gastroesophageal reflux disease.

@en

prefLabel

Current pharmacological management of gastroesophageal reflux disease.

@en

P1476

Current pharmacological management of gastroesophageal reflux disease

@en

P2093

Chao-Hung Kuo

http://www.w3.org/2001/XMLSchema#string

Chiao-Yun Chen

http://www.w3.org/2001/XMLSchema#string

Chien-Yu Lu

http://www.w3.org/2001/XMLSchema#string

Deng-Chyang Wu

http://www.w3.org/2001/XMLSchema#string

Fu-Chen Kuo

http://www.w3.org/2001/XMLSchema#string

Sophie S W Wang

http://www.w3.org/2001/XMLSchema#string

Wen-Hung Hsu

http://www.w3.org/2001/XMLSchema#string

Yao-Kuang Wang

http://www.w3.org/2001/XMLSchema#string

Yu-Chung Su

http://www.w3.org/2001/XMLSchema#string

P2860

Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease

Medical treatments in the short term management of reflux oesophagitis

Control of transient lower oesophageal sphincter relaxations and reflux by the GABA(B) agonist baclofen in patients with gastro-oesophageal reflux disease

Prospective, randomized, and active controlled study of the efficacy of alginic acid and antacid in the treatment of patients with endoscopy-negative reflux disease.

Review article: alginate-raft formulations in the treatment of heartburn and acid reflux.

Mosapride as an adjunct to lansoprazole for symptom relief of reflux oesophagitis.

Japanese herbal medicine in functional gastrointestinal disorders.

Gaviscon® vs. omeprazole in symptomatic treatment of moderate gastroesophageal reflux. a direct comparative randomised trial.

Pharmacokinetic and pharmacodynamic evaluation of a novel proton pump inhibitor, YH1885, in healthy volunteers.

Burden of gastrointestinal disease in the United States: 2012 update.

P304

983653

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2013/983653

http://www.w3.org/2001/XMLSchema#string

P478

2013

http://www.w3.org/2001/XMLSchema#string

P50

Sheau-Fang Yang

P577

2013-06-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

251236024

http://www.w3.org/2001/XMLSchema#string

P698

23878534

http://www.w3.org/2001/XMLSchema#string

P921

gastroesophageal reflux disease

P932

3710614

http://www.w3.org/2001/XMLSchema#string